InvestorsHub Logo

Northstar42

08/16/17 11:17 AM

#16597 RE: BlackDoggie #16595

Agree, the double-blind has not been removed, so results are unknown. Very smart for management to get FDA's agreement to close the Trial, results will soon follow. If positive, we're all going to be very happy, if not,
look out below. BTW, every reason to expect results will we good.

trding

08/16/17 11:19 AM

#16598 RE: BlackDoggie #16595

Though we can't look at the data and Fred has the negative outlook, I have the extreme positive outlook based on history. They had 98% success with mono, Phase 2b study, 4 weeks out which dropped to 91% 6 weeks out; this is 1 week out (with failing ART), I'm expecting 100%


CytoDyn Concludes Phase 2b Study With 98% Success With 4 Weeks of Monotherapy - Many HIV Patients in Extension Study With Some Approaching 6 Months